43 results about "Respiratory symptom" patented technology

The invention discloses a Mycoplasma bovis and application thereof. The Mycoplasma bovis is Mycoplasma bovis HNMB1 and is preserved in China General Microbiological Culture Collection Center with the preservation number of CGMCC NO:13295, the preservation data of November 28th, 2016 and the preservation address of No.3, Courtyard 1, Beichen West Road, Chaoyang District of Beijing. The strain HNMB1 is separated from a diary calf dead due to occurrence of typical respiratory symptoms, no other bacteria grow during separation on a PPLO solid culture medium, only mycoplasmas grow, and proliferation titer in a PPLO liquid culture medium is high and reaches up to more than 10<9>CFU/mL. The strain HNMB1 disclosed by the invention has stronger pathogenicity on the calf, results in pathogenesis and death of the calf and has good immunogenicity.

The invention belongs to the technical field of pharyngitis treatment, aims to solve the problems of long course of treatment and poor effect of the conventional traditional Chinese medicine for treating pharyngitis and provides a traditional Chinese medicine atomizing agent for treating pharyngitis. The traditional Chinese medicine atomizing agent is prepared from dried rehmannia root, scrophulariae, Chinese wolfberries, platycodon grandiflorum, red peony roots, honeysuckle, boat-fruited scaphium seeds, radix ophiopogonis, periostracum cicada and radix glycyrrhizae according to a certain ratio. The traditional Chinese medicines are decocted with conventional water for obtaining medical liquid, the medicine reaches to an affected part through aerosol inhalation, is quick in taking effect, and small in using amount, the concentration of the partial medicine is high, and the respiratory symptom can be improved rapidly. The traditional Chinese medicine atomizing agent can effectively relieve the symptoms of throat red and swollen, urtication, foreign body sensation, cough, difficulty in expectoration, hoarseness and the like.

The invention provides a composition for preventing pneumoconiosis and a preparation method thereof, wherein the composition is prepared from cordyceps militaris, frosted mulberry leaves, tea polyphenols, gingkgo, fructus monordicae extracts, barbary wolfberry fruits, peach kernels, apricot kernels, and malto dextrin, and the preparation method comprises the steps of: (1) soaking the gingkgo, barbary wolfberry fruits, frosted mulberry leaves, peach kernels and apricot kernels in water; (2) heating the soaked materials to be boiling, leaching, then carrying out flocculation precipitation on leach liquor, and concentrating a supernatant fluid into a thick paste; (3) continuously adding water into the rest materials, heating and leaching; (4)mixing and concentrating the two-time extracts into a thick paste, carrying out vacuum drying and then crushing; (5) sieving the extract, and fully mixing with the cordyceps militaris nano powder, malto dextrin, tea polyphenols and fructus monordicae extracts; and (6) fully mixing the extract with the mixture to be uniform, mixing with alcohol, and palletizing. The composition has an obvious free radical scavenging action, reduces ceruloplasmin, obviously restrains pneumoconiosis fibrosis, and greatly improves the respiratory symptoms of patients with pneumoconiosis.

The invention relates to an intelligent control system for controlling side turning of a sickbed through a blood oxygen saturation signal value. The system comprises a blood oxygen measuring device (1), a blood oxygen data conversion module (2), a central control unit (3), an operation instruction display sender (4), a bed turning electric component (5) and a sickbed (6). The oxygen deficit degree of a patient is judged based on the blood oxygen saturation degree value obtained during sleeping of the patient in real time, treatment is carried out based on a sickbed alarm or a side turning scheme given by a blood oxygen data model or based on a scheme set by medical staff in advance, auxiliary medical treatment on the sleep apnea syndrome or other relevant respiratory symptoms is more accurate and scientific, and accidental death of a patient during sleeping without companying or nursing is possibly reduced.

The invention discloses a traditional Chinese medicine oral liquid for treating respiratory diseases of livestock and poultry. The traditional Chinese medicine oral liquid is prepared from the following raw materials: 60-250 of honeysuckle, 50-220g of forsythia, 50-220g of radix isatidis, 50-220 of folium isatidis, 50-220 of radix scutellariae, 50-220g of fritillaria, 50-220g of platycodon grandiflorum, 10-100g of dangshen, 10-100g of astragalus membranaceus and10-100g of liquorice. The traditional Chinese medicine oral liquid can be used for reducing the potential safety hazards caused by chemical drugs, effectively alleviating respiratory symptoms and eliminating or obviously alleviating the inflammatory pathological injuries of tissues and organs of the upper respiratory tracts and the lung and improving the safety of drug use and has a good curative effect.

The invention discloses a traditional Chinese medicine composition for reducing immunological stress reactions of livestock and poultry. The traditional Chinese medicine composition comprises the following raw materials: 2-10 parts of radix astragali and 1 part of manyprickle acanthopanax roots. The traditional Chinese medicine composition disclosed by the invention, after being taken by livestock and poultry before and after being immunized, can reduce immunological stress reactions of vaccines, enhance the immune effect, reduce respiratory symptoms such as snore and cough and the like occurring after poultry vaccination is performed, and improve the appetite loss, slow weight gain and productivity reduction of livestock and poultry caused by immunological stress reactions.

A monitoring and alerting system can be used in any condition with a respiration component. Respiratory symptoms as well as supporting physiological functions are tracked against the user's baseline and alerts the user when there is a worsening trend. The system is self-contained in a wearable that detects and logs the signals, analyzes them and generates alerts. The wearable is untethered during use and may be attached to the body in various manners, such as with adhesives, clothing, clips, belts, chains, necklaces, ear pieces, clothing circuits or the like. Information can further be transmitted both wirelessly and via wire to devices, cloud storage, or the like.

The invention provides compound florfenicol injection as well as a preparation method and application thereof. Each 1000ml of injection comprises 50-300g of florfenicol, 2.5-5g of venenum bufonis, 5-15g of oxymatrine, 5-15g of 654-2, 5-10g of vitamin B1, 0.1-1g of antioxidant, 100ml-800ml of first organic solvent, 100ml-800ml of second organic solvent and 0.1-1g of antioxidant. The compound florfenicol injection is prepared in a step-by-step dissolution mixing manner. The compound florfenicol injection is scientific in formula and has stable property; the components of the compound florfenicol injection have mutual enhancing effects so as to make up for the deficiency. The compound florfenicol injection has a relatively good antibacterial effect, relatively low toxic and side effects and a relatively short treatment course and can be used for preventing and treating diseases with respiratory symptoms, digestive tract symptoms and/or hyperpyrexia symptoms, which are caused by colibacillosis, salmonellosis, pasteurellosis and the like of beast and birds.

The invention discloses a compound preparation of Chinese herbs extract for preventing and treating respiratory disease of livestock and poultry. The compound preparation is prepared from the following raw materials by weight percent: 10-15% of honeysuckle flower extract, 3-7% of radix scutellariae extract, 23-27% of fructus forsythiae extract, 10-15% of herba hyperici perforate extract, 10-15% ofradix isatidis extract, 10-15% of folium isatidis extract, 1-6% of radix platycodi extract, 1-6% of herba menthae extract, 5-10% of radix bupleuri extract, and 1-5% of liquorice root extract, whereinthe sum of the mass percent of the raw materials is 100%. The compound preparation of Chinese herbs extract for preventing and treating respiratory disease of livestock and poultry can lower potential safety hazard caused by chemical antibacterial drugs, has definite curative effects, can relive the respiratory symptoms effectively and eliminate damage of respiratory system tissues, and is applicable to respiratory infection of livestock and poultry caused by viruses and bacteria.

The invention relates to a plant essential oil drinking water solution for eliminating respiratory symptoms of pigs and chickens and a preparation method of the plant essential oil drinking water solution, and belong to the field of medicines of pigs and chickens. The plant essential oil drinking water solution for eliminating respiratory symptoms of pigs and chickens is prepared from the following raw materials in parts by weight: 16-26 parts of an essential oil composition, 8-12 parts of caprylic capric triglycerride, 1-5 parts of sorbitan monostearate60, 4-8 parts of polysorbate60, 2-6 parts of sucrose fatty acid ester and 43-69 parts of water; and the essential oil composition is prepared from 2-10 parts of patchouli essential oil, 2-10 parts of peppermint essential oil and 5-18 partsof eucalyptus oil. The plant essential oil drinking water solution is added to drinking water of pigs and chickens and has obvious improvement and therapeutic effect on eliminating the respiratory symptoms of pigs and chickens; drug resistance, drug residues and toxic and side effects are not produced in long term use; the treatment cost is low, and the plant essential oil drinking water solutioncan be used an antibiotic substitute product to play an important role in animal husbandry production.

The invention relates to a compound minocycline hydrochloride soluble powder for treating respiratory diseases of poultry, which comprises the following components by weight percent: 2-10g of minocycline hydrochloride, 2-10g of cephalosporins cefepime sodium, 10-30g of hypericum perforatum extract (the HPLC detection method is adopted to determine that the hypericin content is more than or equal to 0.30%), 3-8g of kameiding, 2-6g of muramyl dipeptide, 1-6g of amphotericin, and the balance being pharmaceutically applicable excipient. The pharmaceutically applicable excipient is selected from more than one of sucrose, anhydrous glucose and oral glucose, preferably, the anhydrous glucose. The invention uses the latest antibiotics, antiviral drugs, antifungal drugs and novel anti-asthmatic on the market to compound a compound preparation, which has effective curative function for respiratory symptoms of poultry. The invention has reasonable formulation, simple preparation, obvious effect and wide range of application.

The invention discloses a compound Ofloxacin solution and a preparation method thereof, aiming at providing a solution with the advantages of treating digestive tract infections and respiratory tract infections of birds with rapid effect, treating both principal and secondary aspects of diseases and reducing drug-applied times and a preparation method thereof. The solution can be injected or orally taken and proper treating methods and administration approaches can be adopted according to disease states and the specific conditions of culturists. Every 100L of solutions comprises 1-10 kg of Ofloxacin, 3-15 kg of lincomycin hydrochloride, 0.05-0.5 kg of atropine sulfates, 0.2-2 kg of doxofylline, 0.01 kg of EDTA (Ethylene Diamine Tetraacetic Acid)-2Na, 10 kg of dimethylacetylamide and 0.5 L of hydrochloric acid. Because the Ofloxacin and the lincomycin hydrochloride are adopted as antibacterial components, the compound Ofloxacin solution can effectively solve the problems of bacterial drug resistance and takes effect on common bacteria causing the digestive tract infections and the respiratory tract infections; and meanwhile, the doxofylline can effectively relieve cough and asthma and inhibit respiratory symptoms, and the atropine sulfates have the rapid effects of inhibiting glandular secretion and reducing the liquid contents of digestive tracts and the respiratory tracts.

The invention discloses a haemophilus paragallinarum and application thereof. The haemophilus paragallinarum is haemophilus paragallinarum HNHpg1, the preservation number is CGMCC NO:13859, the preservation date is May 26th, 2017, the preservation place is China General Microbiological Culture Collection Center and the preservation address is Beijing, China. The haemophilus paragallinarum HNHpg1 is separated from secreta of sinus infraorbitalis of a laying hen suffering from typical respiratory symptoms and head and facial swelling, has stable biological characteristics, has stronger pathogenicity on chicks, can result in morbidity and death of the chicks and has good immunogenicity. A vaccine prepared by utilizing the haemophilus paragallinarum HNHpg1 disclosed by the invention is safe and reliable and has a better protective effect on chicken infectious rhinitis.

The invention discloses a respiratory tract symptom detection method based on smart phone audio perception in a driving environment. According to the method, a loudspeaker of a smart phone is used forcollecting sounds in a vehicle, vehicle driving noise is filtered out based on a self-adaptive sub-band spectral entropy method, then acoustic characteristics of the denoised sound are extracted andsent to a trained neural network, and whether respiratory tract symptoms such as cough, sneezing and nasal aspiration exist in the collected sound or not is judged. And the frequency of related respiratory tract symptoms is recorded. The method does not depend on various professional medical devices erected in advance, is low in cost and high in anti-interference performance, does not have the privacy leakage problem, and is suitable for the detection environment where driving noise is stable and the distance between a driver and passengers is short. According to the method, the influence of various driving noises is eliminated by adopting a denoising method based on the adaptive sub-band spectral entropy, so that the robustness of the system to environmental noises is relatively high, andthe detection and classification of three typical respiratory tract symptoms can be accurately and efficiently realized.

A monitoring and alerting system can be used in any condition with a respiration component. Respiratory symptoms as well as supporting physiological functions are tracked against the user's baseline and alerts the user when there is a worsening trend. The system is self-contained in a wearable that detects and logs the signals, analyzes them and generates alerts. The wearable is untethered during use and may be attached to the body in various manners, such as with adhesives, clothing, clips, belts, chains, necklaces, ear pieces, clothing circuits or the like. Information can further be transmitted both wirelessly and via wire to devices, cloud storage, or the like.

A chilled-air inhaler device for the alleviation of respiratory symptoms includes a body containing a hollow chamber through which air is forced or drawn past at least an air-chilling surface. In an embodiment the air-chilling surface may include water ice. Connected to the body and hollow chamber at one end is a mouthpiece including an opening that connects from environmental air outside of the hollow chamber to the hollow chamber. Connected to the hollow chamber at a second end is an inlet which connects to a source of air. In an embodiment, the inlet may connect to an external device such blower or nebulizer.

The invention provides a traditional Chinese medicinal composition for preventing and treating infectious bronchitis of chickens. The raw materials of the traditional Chinese medicinal composition comprise acanthopanax root, liquorice and platycodon grandiflorum, wherein the ratio of the liquorice to the platycodon grandiflorum is 2:1; the ratio of the acanthopanax root to the liquorice to the platycodon grandiflorum is 4:2:1 to 1:2:1. The traditional Chinese medicinal composition provided by the invention can effectively prevent and treat the infectious bronchitis of the chickens, has remarkable effects of preventing weight reduction of the chickens and relieving respiratory symptom, and has the characteristics of quick response, accurate curative effect, no medicinal residues and no toxic or side effect. The invention further provides a preparation method of the traditional Chinese medicinal composition. The preparation method of the traditional Chinese medicinal composition is simple in process and suitable for the requirement of large-scale industrialized production.

The invention discloses a pharmaceutical composition for preventing and treating a poultry air sac inflammation and a preparation method thereof .The pharmaceutical composition for preventing and treating the poultry air sac inflammation is prepared from nervate twayblade herb, fig fruit, cortex fraxini, platycodon roots, licorice roots, betel nuts, tsaoko amomum fruit, officinal magnolia bark, Chinese thorowax roots, baical skullcap roots, raw lotus leaves, herba houttuyniae, pine needles, opuntia dillenii Haw., radix sophorae flavescentis, fructus forsythiae, mulberry leaves, honeysuckle flowers, common fenugreek seeds, dried tangerine peel, Chinese wax gourd peel, peach flowers, Chinese lobelia herb, radix gentianae and radix ophiopogonis by weight .The traditional Chinese medicine preparation has the complementary and synergistic effects on treating pathology of the poultry air sac inflammation, is mild in drug property, free of irritation to respiratory mucosae, capable of rapidly relieving respiratory symptoms caused by air sac inflammation type respiratory diseases and repairing the respiratory mucosae, stable in drug efficacy and lasting in effect and can obviously cure or relieve poultry air sac inflammation symptoms, decrease poultry death rate and reduce losses.

The invention provides a TCM (Traditional Chinese Medicine) aerosol for treating respiratory diseases of birds. The TCM aerosol mainly comprises 44.4 to 64.5 parts of Raidx Astragali, 3.45 to 6.45 parts of Propolis, 6.67 to 12.5 parts of Schisandra, 19.4 to 20.8 parts of Mangnolia officinalis and 34.5 to 44.5 parts of Licorice by weight. The TCM aerosol for treating respiratory diseases of birds can be absorbed quickly, can be directly reach the focus, can be kept in higher concentration at the phlogistic parts, particularly at nasal cavities, tracheas, bronchus, lungs, pneumatocysts and other organs, can radically kill pathogens at pneumatocysts and lungs, relieves respiratory symptoms, has high efficiency, can be administered less frequently, is convenient to use, and has strong practicability.

A traditional Chinese medicine for treating viral respiratory infection comprises the following ingredients: herba houttuyniae, dandelion, chrysanthemum, pogostemon cablin, scandent schefflera stem and leaf and tinospora sinensis merr. The traditional Chinese medicine has the advantages as follows: 1, the traditional Chinese medicine has no side effect, and is mainly used for treating respiratorysymptoms such as sphagitis, bronchitis, pulmonary disease, etc.; and 2, the traditional Chinese medicine can eliminate phlegm, relieve a cough, resist inflammation, reduce swelling, clear away heat and toxic materials, increase antibody metabolism and antiviral functions, and enhance immunity.

The invention relates to the technical field of microorganisms, and in particular relates to a composition and a preparation method and application in preparing an immune adjuvant of the composition.The combination provided by the present invention comprises prebiotics, probiotics, euglena polysaccharide, solid corn syrup and erythritol. The research results show that the efficiency of vaccines can be enhanced by the joint application of microecological immune adjuvant and respiratory vaccine to help children prevent respiratory tract infections, especially upper respiratory tract infections,the recovery period is shortened, the duration of respiratory symptoms is reduced, and the oral microecological immune adjuvant of the invention is simple to prepare and easy to industrially produce.

Respiratory symptoms resulting from disease states such as PRRS and Streptococcus infections can be alleviated by administration of electrolyzed water via fog or mist delivery in an animal confinement. The delivery may be in doses spaced evenly throughout the day and may include delivery of between about 1 and about 6 gallons per dose. In one embodiment, the dose is delivered via a distribution system of nozzles over a time period of about 1 minute. In others, the delivery may require 5, 10 or 20 minutes and may include components in addition to the electrolyzed water. It is understood that the mist is inhaled, and is also distributed onto the surfaces in the confinement and on the animals themselves.